应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02096 先声药业
已收盘 01-09 16:08:35
12.150
+0.020
+0.16%
最高
12.240
最低
11.900
成交量
673.90万
今开
12.060
昨收
12.130
日振幅
2.80%
总市值
315.41亿
流通市值
315.41亿
总股本
25.96亿
成交额
8,139万
换手率
0.26%
流通股本
25.96亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
先声药业(02096)12月股份变动月报表,股本维持不变
公告速递 · 01-06 16:36
先声药业(02096)12月股份变动月报表,股本维持不变
每日卖空追踪 | 先声药业 01月06日卖空量成交14.8万股,卖空比例为2.71%
市场透视 · 01-06 16:30
每日卖空追踪 | 先声药业 01月06日卖空量成交14.8万股,卖空比例为2.71%
医药大省集采来袭!7个超10亿重磅在列,独家中成药“霸屏”,恒瑞、先声、步长亮眼
米内网 · 01-06 16:25
医药大省集采来袭!7个超10亿重磅在列,独家中成药“霸屏”,恒瑞、先声、步长亮眼
21亿脑卒中治疗药物争夺赛起:江苏联环药业等12家药企猛攻,先声药业重磅新药首仿资格花落谁家?
Ofweek维科网 · 01-06
21亿脑卒中治疗药物争夺赛起:江苏联环药业等12家药企猛攻,先声药业重磅新药首仿资格花落谁家?
2030年市场规模有望突破210亿,失眠药物市场加速放量!
化工邦 · 01-06
2030年市场规模有望突破210亿,失眠药物市场加速放量!
每日卖空追踪 | 先声药业 01月05日卖空量成交41.7万股,卖空比例为6.54%
市场透视 · 01-05
每日卖空追踪 | 先声药业 01月05日卖空量成交41.7万股,卖空比例为6.54%
先声药业01月05日主力净流入176.9万元 散户资金抛售
市场透视 · 01-05
先声药业01月05日主力净流入176.9万元 散户资金抛售
恒瑞前董事长周云曙履新先声药业,曾在恒瑞工作超25年
澎湃新闻 · 01-04
恒瑞前董事长周云曙履新先声药业,曾在恒瑞工作超25年
周云曙履新先声药业总裁,“医药老将”回归引关注
医药经济报 · 01-04
周云曙履新先声药业总裁,“医药老将”回归引关注
每日卖空追踪 | 先声药业 01月02日卖空量成交8.8万股,卖空比例为7.82%
市场透视 · 01-02
每日卖空追踪 | 先声药业 01月02日卖空量成交8.8万股,卖空比例为7.82%
先声药业01月02日遭主力抛售115.3万元
市场透视 · 01-02
先声药业01月02日遭主力抛售115.3万元
每日卖空追踪 | 先声药业 12月31日卖空量成交33.1万股,卖空比例为19.43%
市场透视 · 2025-12-31
每日卖空追踪 | 先声药业 12月31日卖空量成交33.1万股,卖空比例为19.43%
【瞩目】联环药业抢首仿,剑指大卖20亿的1类新药
米内网 · 2025-12-31
【瞩目】联环药业抢首仿,剑指大卖20亿的1类新药
先声药业,接连交易,赢麻了
动脉网 · 2025-12-31
先声药业,接连交易,赢麻了
每日卖空追踪 | 先声药业 12月29日卖空量成交23万股,卖空比例为1.93%
市场透视 · 2025-12-29
每日卖空追踪 | 先声药业 12月29日卖空量成交23万股,卖空比例为1.93%
【重磅】17亿大品种,浙江药企获批了
米内网 · 2025-12-29
【重磅】17亿大品种,浙江药企获批了
先声药业12月29日遭主力抛售925.1万元
市场透视 · 2025-12-29
先声药业12月29日遭主力抛售925.1万元
国金证券:首予先声药业(02096)“买入”评级 目标价20.16港元
智通财经 · 2025-12-29
国金证券:首予先声药业(02096)“买入”评级 目标价20.16港元
光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事
时代周报 · 2025-12-25
光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事
先声药业12月24日遭主力抛售79.4万元
市场透视 · 2025-12-24
先声药业12月24日遭主力抛售79.4万元
加载更多
公司概况
公司名称:
先声药业
所属市场:
SEHK
上市日期:
--
主营业务:
先声药业集团有限公司是一家从事药品的研发、生产和销售的公司。该公司的主要产品为仿制药,包括用于中枢神经系统疾病的产品必存、用于肿瘤疾病的产品捷百舒和捷佰立、以及用于自身免疫疾病的产品英太青。该公司还从事生产创新药,比如用于肿瘤疾病的恩度。该公司还从事为医疗机构销售的第三方药品提供推广服务。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"先声药业","latestPrice":12.15,"timestamp":1767946115005,"preClose":12.13,"halted":0,"volume":6739000,"delay":0,"floatShares":2596000000,"shares":2596000000,"eps":0.3257887828703271,"marketStatus":"已收盘","change":0.02,"latestTime":"01-09 16:08:35","open":12.06,"high":12.24,"low":11.9,"amount":81393153,"amplitude":0.02803,"askPrice":12.16,"askSize":43000,"bidPrice":12.15,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.39969129398559533,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":12.13,"dividendRate":0.014387,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":1.248637,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096","defaultTab":"news","newsList":[{"id":"1187203277","title":"先声药业(02096)12月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1187203277","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187203277?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:36","pubTimestamp":1767688591,"startTime":"0","endTime":"0","summary":"先声药业集团有限公司(香港注册成立,股份代码:02096)于2026年1月6日发布截至2025年12月31日的股份变动月报表。报告期内,公司已发行及库存股份数目无新增发行、购回或注销,普通股本月底结存与上月底保持一致,为2,595,697,618股。\n根据公告,公司现行的限制性股份单位计划于2023年6月15日修订并重列,并曾于2025年12月1日授出15,408,100份限制股份单位,惟当月并未导致股份实际增发。公告由执行董事及联席公司秘书万玉山签署,公司确认遵守香港联交所上市规则及相关法律法规,截至12月底公司股本维持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"2601843728","title":"每日卖空追踪 | 先声药业 01月06日卖空量成交14.8万股,卖空比例为2.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601843728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601843728?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:30","pubTimestamp":1767688227,"startTime":"0","endTime":"0","summary":"先声药业北京时间01月06日,涨0.92%,卖空量成交14.8万股,较上一交易日减少82.36%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163412a4a2891f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163412a4a2891f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1191","BK1583"],"gpt_icon":0},{"id":"2601843748","title":"医药大省集采来袭!7个超10亿重磅在列,独家中成药“霸屏”,恒瑞、先声、步长亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2601843748","media":"米内网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601843748?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:25","pubTimestamp":1767687948,"startTime":"0","endTime":"0","summary":"化药方面,均为临床用量较大、采购金额较高、院内使用成熟的品种。此外,9个OTC中成药品种拟纳入本批集采,占比高达75%,包括神农镇痛膏、麝香海马追风膏、银黄颗粒、黄连上清胶囊、安神补脑液、疏风解毒胶囊等。业内观点认为,独家品种与OTC品种协同纳入,将推动中成药集采从医院终端向零售市场延伸,形成“全方位覆盖、多层次管控”体系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106170418a4a2ad36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106170418a4a2ad36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","BK1515","02096","09939","BK1583","BK1161"],"gpt_icon":0},{"id":"2601736843","title":"21亿脑卒中治疗药物争夺赛起:江苏联环药业等12家药企猛攻,先声药业重磅新药首仿资格花落谁家?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601736843","media":"Ofweek维科网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601736843?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:17","pubTimestamp":1767687477,"startTime":"0","endTime":"0","summary":"截图来源:全终端医院销售数据库截至目前,包含江苏联环药业在内,已有12家国内药企加入依达拉奉右莰醇注射用浓溶液的国内首仿争夺之中。截至目前,江苏联环药业有44个品种获批并通过一致性评价,其中盐酸多西环素片、盐酸屈他维林注射液、盐酸屈他维林片、盐酸舍曲林胶囊4款为首家过评品种。结语依达拉奉右莰醇注射用浓溶液的首仿争夺趋于白热化,12家药企的激烈竞争,预示着这一21亿级重磅品种的市场格局即将重塑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161836a4a276e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161836a4a276e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2601843742","title":"2030年市场规模有望突破210亿,失眠药物市场加速放量!","url":"https://stock-news.laohu8.com/highlight/detail?id=2601843742","media":"化工邦","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601843742?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:16","pubTimestamp":1767687369,"startTime":"0","endTime":"0","summary":"有数据显示,中国失眠药物市场由2017年的102.8亿元增至2021年的122.8亿元。据预测,2025年这一市场规模将达151.2亿元,到2030年有望达到211.9亿元。据悉,除了京新药业外,当前还有不少药企正在积极布局失眠药物。接连多个双食欲素受体拮抗剂获批上市,这也预示着中国失眠治疗领域正式迎来靶向治疗新时代,一个规模超200亿元的蓝海市场正在加速重构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163154a6f980e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163154a6f980e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2601812148","title":"每日卖空追踪 | 先声药业 01月05日卖空量成交41.7万股,卖空比例为6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601812148?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601826,"startTime":"0","endTime":"0","summary":"先声药业北京时间01月05日,涨1.02%,卖空量成交41.7万股,较上一交易日增加106.44%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163508a49e28fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163508a49e28fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2601881262","title":"先声药业01月05日主力净流入176.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601881262","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601881262?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600956,"startTime":"0","endTime":"0","summary":"01月05日, 先声药业股价涨1.02%,报收11.92元,成交金额7611.4万元,换手率0.25%,振幅4.24%,量比1.04。先声药业今日主力资金净流入176.9万元,上一交易日主力净流出115.3万元。该股近5个交易日下跌6.50%,主力资金累计净流出1564.2万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出3302.2万元,其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162231a6f514c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162231a6f514c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1191","BK1583"],"gpt_icon":0},{"id":"2600846042","title":"恒瑞前董事长周云曙履新先声药业,曾在恒瑞工作超25年","url":"https://stock-news.laohu8.com/highlight/detail?id=2600846042","media":"澎湃新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600846042?lang=zh_cn&edition=full","pubTime":"2026-01-04 16:14","pubTimestamp":1767514482,"startTime":"0","endTime":"0","summary":"从恒瑞离职四年多后,周云曙履新港股创新药企先声药业。但2021年7月9日,恒瑞医药公告称,董事会近日收到公司董事长、总经理周云曙的辞职报告,周云曙因身体原因申请辞去公司董事长、总经理以及董事会专门委员会相应职务,创始人孙飘扬回归。目前,先声药业的业务主要集中在神经系统、肿瘤、自身免疫等领域。先声药业已获批上市有10款创新药,其中5款贡献稳定现金流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104161625a6f12bc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104161625a6f12bc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1583","01276","BK1191"],"gpt_icon":0},{"id":"2600428900","title":"周云曙履新先声药业总裁,“医药老将”回归引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2600428900","media":"医药经济报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600428900?lang=zh_cn&edition=full","pubTime":"2026-01-04 11:57","pubTimestamp":1767499065,"startTime":"0","endTime":"0","summary":"据业内消息确认,周云曙已正式履职先声药业集团总裁一职。2025年12月27日,在江苏省肿瘤医院与先声药业的战略合作签约仪式现场,周云曙首次以先声药业集团总裁的身份公开亮相。前后东家的战略对勘周云曙此次加盟的先声药业,近年来展现出强劲的发展势头。目前,先声药业正在多个领域建立优势。对于现年55岁的周云曙来说,这次职业变动不仅是个人职业生涯的转折点,也引发了医药行业的广泛关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104121307a6f081c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104121307a6f081c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1515","BK1574","01276","09939","02096","BK1161"],"gpt_icon":1},{"id":"2600095247","title":"每日卖空追踪 | 先声药业 01月02日卖空量成交8.8万股,卖空比例为7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600095247","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600095247?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342628,"startTime":"0","endTime":"0","summary":"先声药业北京时间01月02日,跌1.42%,卖空量成交8.8万股,较上一交易日减少73.41%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163313a6eb2a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163313a6eb2a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2600095221","title":"先声药业01月02日遭主力抛售115.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600095221","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600095221?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:16","pubTimestamp":1767341763,"startTime":"0","endTime":"0","summary":"01月02日, 先声药业股价跌1.42%,报收11.80元,成交金额1324.1万元,换手率0.04%,振幅3.01%,量比0.17。先声药业今日主力资金净流出115.3万元,上一交易日主力净流出565.0万元。该股近5个交易日下跌8.29%,主力资金累计净流出1942.5万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出2512.0万元,其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102162053a6eb21ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102162053a6eb21ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2595722653","title":"每日卖空追踪 | 先声药业 12月31日卖空量成交33.1万股,卖空比例为19.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595722653","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595722653?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:30","pubTimestamp":1767169827,"startTime":"0","endTime":"0","summary":"先声药业北京时间12月31日,涨0.42%,卖空量成交33.1万股,较上一交易日增加21.69%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163401a48dc71f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163401a48dc71f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2600004047","title":"【瞩目】联环药业抢首仿,剑指大卖20亿的1类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2600004047","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600004047?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:24","pubTimestamp":1767169491,"startTime":"0","endTime":"0","summary":"精彩内容12月31日,江苏联环药业提交了依达拉奉右莰醇注射用浓溶液的4类仿制上市申请获得CDE承办。该产品是先声药业于2020年获批的1类新药,2024年在中国三大终端六大市场的销售额超过21亿元。截至目前,包括江苏联环药业在内已有10家国内药企冲击依达拉奉右莰醇注射用浓溶液的国内首仿,在今年11月凯宝药业以失败告终,该产品的首仿之争结果难料,有待继续观察。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231194230a48e794d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231194230a48e794d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"2595722537","title":"先声药业,接连交易,赢麻了","url":"https://stock-news.laohu8.com/highlight/detail?id=2595722537","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595722537?lang=zh_cn&edition=full","pubTime":"2025-12-31 10:10","pubTimestamp":1767147000,"startTime":"0","endTime":"0","summary":"12月22日,先声药业与Ipsen签订独家授权许可协议,Ipsen获SIM0613海外独家开发等权利,先声药业最高可收10.6亿美元款项。2025年,先声药业三款多抗及ADC产品成功授权,跻身BD第一梯队,实现由仿到创转型。2025年上半年,先声药业收入35.85亿元,同比增长15.1%,经调整净利润6.5亿元,同比增长21.1%,源于创新药快速放量,且创新药占比达77.4%,较2024年提升3.1%。尽管其创新药占比曾超50%,但过去未获资本市场认可,如今创新药企价值重估浪潮下,先声药业迎来新机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231101445a6e37653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231101445a6e37653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2595731959","title":"每日卖空追踪 | 先声药业 12月29日卖空量成交23万股,卖空比例为1.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595731959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595731959?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997026,"startTime":"0","endTime":"0","summary":"先声药业北京时间12月29日,跌6.89%,卖空量成交23万股,较上一交易日减少44.17%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163354a6dc4944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163354a6dc4944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2595731692","title":"【重磅】17亿大品种,浙江药企获批了","url":"https://stock-news.laohu8.com/highlight/detail?id=2595731692","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595731692?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:25","pubTimestamp":1766996755,"startTime":"0","endTime":"0","summary":"精彩内容近日,国家药监局官网显示,浙江高跖医药的4类仿制药艾拉莫德片获批上市、视同过评,为公司首款风湿病治疗药。在中国三大终端六大市场,艾拉莫德片2024-2025Q1~Q3销售额均超过17亿元,同比增长25.28%和29.69%。在中国三大终端六大市场,艾拉莫德片近年来销售额均保持两位数的同比增幅,2022年首度突破10亿元大关;2025Q1~Q3继续以29.69%的增速增长至超17亿元,为抗炎药和抗风湿药TOP1产品。今年以来浙江高跖医药获批上市新品来源:米内网中国申报进度数据库","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163830a4854f3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163830a4854f3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"2595316487","title":"先声药业12月29日遭主力抛售925.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595316487","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595316487?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996122,"startTime":"0","endTime":"0","summary":"12月29日, 先声药业股价跌6.89%,报收11.89元,成交金额1.4亿元,换手率0.46%,振幅8.93%,量比1.99。先声药业今日主力资金净流出925.1万元,连续6日净流出,上一交易日主力净流出135.7万元。该股近5个交易日下跌6.81%,主力资金累计净流出3280.8万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1893.0万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161633a6dc33f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161633a6dc33f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2595208146","title":"国金证券:首予先声药业(02096)“买入”评级 目标价20.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595208146","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595208146?lang=zh_cn&edition=full","pubTime":"2025-12-29 10:13","pubTimestamp":1766974404,"startTime":"0","endTime":"0","summary":"根据DCF估值,对应合理目标价为20.16港币,首次覆盖,给予“买入”评级。国金证券主要观点如下:创新转型成效显著,创新药收入占比持续提升至77%公司聚焦神经、肿瘤、自免及抗感染四大核心治疗领域,深耕市场三十年。凭借自研+BD双轮驱动,商业化创新药已增至10款,创新药收入占比从2020年的45%提升至2025H1的77%,收入结构持续优化,创新转型成果显著。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096"],"gpt_icon":0},{"id":"2594287939","title":"光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287939","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594287939?lang=zh_cn&edition=full","pubTime":"2025-12-25 14:21","pubTimestamp":1766643688,"startTime":"0","endTime":"0","summary":"今年创新药企业频繁宣布BD交易,但从三季度以来,原本利好的消息却不被二级市场买账。最近一周,BD交易再掀一个小高潮。12月22日,先声药业(02096.HK)宣布其附属公司江苏再明与Ipsen于12月19日签订独家授权许可协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512253601825588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064130708.USD","600276","LU0405327148.USD","06978","LU1997245177.USD","LU2097828474.EUR","BK1593","LU1146622755.USD","LU1997245094.SGD","LU2495084118.USD","02142","02509","688336","BK0196","BK1589","LU2097828631.EUR","09995","LU0502904849.HKD","000661","LU1064131003.USD","LU2148510915.USD","BK0057","BK0060","BK0012","LU1781817850.SGD","02096","LU1997244956.HKD","688062","LU2488822045.USD","688331","LU1969619763.USD","LU2097828714.EUR","LU2097828557.USD","01530","BK1574","01167","688428","LU2580892862.HKD","BK0239","BK1161","LU2097828805.USD","LU1328615791.USD","BK0028","BK0183","603087","01801","BK0188","03692","002755","LU0405327494.USD"],"gpt_icon":0},{"id":"2593477780","title":"先声药业12月24日遭主力抛售79.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477780?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:15","pubTimestamp":1766564121,"startTime":"0","endTime":"0","summary":"12月24日, 先声药业股价跌1.01%,报收12.77元,成交金额3171.6万元,换手率0.09%,振幅3.26%,量比0.39。先声药业今日主力资金净流出79.4万元,连续6日净流出,上一交易日主力净流出135.7万元。该股近5个交易日上涨1.35%,主力资金累计净流出2435.1万元;近20日主力资金累计净流出1047.3万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161624a4726a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161624a4726a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02096","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":-0.121},{"period":"3month","weight":-0.0288},{"period":"6month","weight":0.1619},{"period":"1year","weight":0.8404},{"period":"ytd","weight":0.0134}],"compareEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.0281},{"period":"3month","weight":-0.0054},{"period":"6month","weight":0.0833},{"period":"1year","weight":0.3563},{"period":"ytd","weight":0.0202}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先声药业集团有限公司是一家从事药品的研发、生产和销售的公司。该公司的主要产品为仿制药,包括用于中枢神经系统疾病的产品必存、用于肿瘤疾病的产品捷百舒和捷佰立、以及用于自身免疫疾病的产品英太青。该公司还从事生产创新药,比如用于肿瘤疾病的恩度。该公司还从事为医疗机构销售的第三方药品提供推广服务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.087055},{"month":2,"riseRate":0.6,"avgChangeRate":0.07279},{"month":3,"riseRate":0.4,"avgChangeRate":-0.021724},{"month":4,"riseRate":0.6,"avgChangeRate":0.009116},{"month":5,"riseRate":0.8,"avgChangeRate":0.158743},{"month":6,"riseRate":0.6,"avgChangeRate":0.036684},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0521},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05132},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0324},{"month":10,"riseRate":0.8,"avgChangeRate":0.108781},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044275},{"month":12,"riseRate":0.5,"avgChangeRate":0.000552}],"exchange":"SEHK","name":"先声药业","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先声药业,02096,先声药业股票,先声药业股票老虎,先声药业股票老虎国际,先声药业行情,先声药业股票行情,先声药业股价,先声药业股市,先声药业股票价格,先声药业股票交易,先声药业股票购买,先声药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}